+499.5%
MRNA vs UAL
+5.0%
+494.5%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | UAL | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +2.5% | -4.7% | -2.6% |
| 7D | +5.5% | +0.7% | +4.8% | +5.4% |
| 30D | +158.7% | -16.1% | +174.8% | +169.2% |
| 3M | +182.1% | +6.1% | +176.0% | +175.2% |
| 6M | +151.8% | +10.8% | +141.0% | +139.4% |
| YTD | +393.6% | -0.4% | +394.0% | +374.4% |
| 1Y | +499.5% | +5.0% | +494.4% | +483.2% |
| All | +499.5% | +5.0% | +494.5% | +483.2% |
Cumulative growth
Daily Returns
Daily percentage return beside UAL.
Daily Out/Under-Performance
Portfolio return minus UAL return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × UAL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded UAL wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling